DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Glintborg B, Sørensen IJ, Loft AG. et al
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Annals of the Rheumatic Diseases 2017;
76: 1426-1431
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.